Drugs / CD123/CLL1 CAR-T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03631576 | Aug 2018 → Aug 2021 | acute myeloid leukemia | Fujian Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD123/CLL1 CAR-T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03631576 ↗ |
| Modality | Cell therapy | “CD123/CLL1 CAR-T Cells” NCT03631576 ↗ |